MENU
Go to the list of all blogs
Niko Sharks's Avatar
published in Blogs
Jul 25, 2023

$SSE (SSEZY) to Pay Dividends on September 28, 2023: A Financial Snapshot

SSE (SSEZY), a leading energy company, is set to pay dividends on September 28, 2023. In what appears to be an attractive yield for shareholders, a dividend of $0.84 per share will be paid. This is an important event that needs to be watched closely by investors, as dividend payments often reflect a company's profitability and financial health.

It's crucial for investors to note the record date, which is the cut-off point at which shareholders must be registered to receive the upcoming dividend. In SSE's case, this date is set for September 28, 2023. Moreover, the ex-dividend date, which is typically a few business days before the record date, has been announced as July 27, 2023.

To clarify, the ex-dividend date is a significant milestone. If a stock is purchased on or after the ex-dividend date, the next dividend payment will not be received by the buyer. Instead, it will be repossessed by the seller. Therefore, those wishing to receive this $0.84 dividend need to ensure that they hold SSE shares prior to July 27, 2023.

For context, the last dividend paid by SSE was $0.34 per share on March 16, 2023. This indicates a significant increase in the upcoming dividend, more than doubling the previous payout. Such an increase could potentially signal robust financial performance or a strategic move by the company to increase returns to shareholders.

This significant increase in the dividend payout may also signal SSE's confidence in its future earnings and financial stability. A higher dividend payout can indicate strong current performance and the expectation of robust future earnings, which may attract new investors while retaining existing ones.

However, investors should not rely solely on the dividend yield when evaluating a company. A thorough analysis of the company's earnings, financial health, and market conditions is also important. It's crucial to look beyond the dividend yield and understand what's driving the company's ability to maintain or increase its dividend payments.

The upcoming dividend payment by SSE could present an attractive opportunity for income-seeking investors. However, it's crucial for those interested in benefiting from this dividend to purchase the shares before the ex-dividend date on July 27, 2023. As always, potential investors should perform a comprehensive analysis of the company before making any investment decisions.

Related Ticker: SSEZY
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry ElectricUtilities

Profile
Fundamentals
Details
Industry
N/A
Address
200 Dunkeld Road
Phone
+44 1738456000
Employees
12180
Web
https://www.sse.com
Interact to see
Advertisement
Learn how to identify the four key market phases—Accumulation, Uptrend, Distribution, and Downtrend—and strategically trade each using Tickeron’s AI-powered Double Agent system. Discover how adaptive automation helps maximize gains and minimize risk across all market conditions.
#investment#artificial_intelligence
Learn how to identify the four key market phases—Accumulation, Uptrend, Distribution, and Downtrend—and strategically trade each using Tickeron’s AI-powered Double Agent system. Discover how adaptive automation helps maximize gains and minimize risk across all market conditions.
#artificial_intelligence#trading
Tickeron, a leader in AI-powered financial solutions, proudly announces the launch of its Double Agent Trading Bot, designed for trading Carpenter Technology Corporation (CRS) and Direxion Daily Semiconductor Bear 3x Shares (SOXS).
#artificial_intelligence
Apple Inc. (AAPL), a global leader in consumer electronics, continues to be a cornerstone of the technology sector, driving innovation and commanding significant market attention.
#artificial_intelligence
NVIDIA’s earnings on May 28 could jolt the tech sector. With market volatility rising, traders are turning to Tickeron’s AI Agent for real-time insights, predictive analytics, and dual-strategy trading tools to navigate potential price swings and seize market opportunities.
#artificial_intelligence
As the DOJ and FTC move to break up Google’s search dominance and impose AI investment oversight, the tech giant faces a pivotal legal battle that could reshape the digital and AI landscapes—creating major implications for investors, competitors, and consumers alike.
#artificial_intelligence
GameStop (GME) continues to captivate investors with its explosive volatility and strong retail sentiment. As AI tools highlight bullish signals and a possible breakout, traders weigh the risks of speculation against the potential rewards in May 2025.
#artificial_intelligence
Mastercard (MA) continues to impress investors with strong earnings, rising digital payments, and bullish AI-driven signals. Backed by robust financials and cutting-edge trading tools from Tickeron, MA stands out as a leader in the fintech space for 2025.
From Walmart's retail resilience to Exxon Mobil's energy strength, May 2025 highlights key market movers. Discover how Tickeron’s AI bots analyze WMT, IVW, COST, and XOM—uncovering trends, boosting trading strategies, and navigating market volatility with precision.
#trading#artificial_intelligence
A powerful recession signal is flashing red: the Leading/Lagging Ratio has plunged to levels not seen since 2008. As markets grow turbulent, smart investors are turning to Tickeron’s AI trading agents to spot opportunities and stay ahead of the downturn.
#trading#artificial_intelligence
AI trading bots are no longer just experimental—they’re outperforming traditional strategies. Discover how bots trading ITA, TSM, META, and others achieved over 40% annual returns and what this means for the future of investing.
FingerMotion (FNGR) is making waves in 2025 with a 52% stock surge, strategic AI expansion into Indonesia, and strong retail momentum. Learn how traders are using correlation analysis, inverse ETFs, and Tickeron’s AI tools to navigate FNGR’s dynamic moves.
#artificial_intelligence#trading
Ferrari (RACE) is accelerating in 2025 with a 25% YTD gain, strong earnings, and bullish momentum fueled by innovation and Lewis Hamilton’s F1 move. Discover how Tickeron’s AI tools help traders capitalize on this luxury stock’s high-performance potential.
Intel’s stock is down 64%, but a bold turnaround under new CEO Lip-Bu Tan and the upcoming 18A chip rollout could spark a rebound. This article explores Intel’s financials, strategic shifts, and how AI tools from Tickeron help traders navigate the volatility.
#artificial_intelligence
Dogecoin (DOGE) fell 12.78% in five days, rattled by whale activity, Musk headlines, and ETF rumors. Is a breakout coming—or more downside? Explore key trends, technical levels, and how Tickeron’s AI bots help traders navigate DOGE’s next move.
The week of June 2-6, 2025, saw financial markets demonstrate resilience amid U.S.-China trade tensions and key economic data releases.
Tesla, Inc. (TSLA), a global leader in electric vehicles (EVs) and artificial intelligence (AI)-driven technologies, has been a focal point for investors in 2025.
#artificial_intelligence#trading
As artificial intelligence continues to reshape the financial industry, AI-powered trading agents have emerged as influential tools in portfolio management and speculative trading.
#investment#artificial_intelligence
Amazon (NASDAQ: AMZN) remains a cornerstone of the technology and e-commerce sectors, consistently driving innovation and market influence.
#artificial_intelligence
ntroduction to Eli Lilly and Company (LLY) Eli Lilly and Company (LLY), a global pharmaceutical giant, has been a cornerstone of the healthcare sector since its founding in 1876. Headquartered in Indianapolis, Indiana, the company specializes in developing innovative treatments for diabetes, oncology, immunology, and neuroscience, with blockbuster drugs like Mounjaro and Zepbound driving significant…